U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H38N2O.ClH
Molecular Weight 419.043
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUNAMIDINE HYDROCHLORIDE

SMILES

Cl.CCCCCCOC1=CC=C(C(=N)N(CCCC)CCCC)C2=CC=CC=C12

InChI

InChIKey=PBYJDHRFPFHVKZ-UHFFFAOYSA-N
InChI=1S/C25H38N2O.ClH/c1-4-7-10-13-20-28-24-17-16-23(21-14-11-12-15-22(21)24)25(26)27(18-8-5-2)19-9-6-3;/h11-12,14-17,26H,4-10,13,18-20H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula C25H38N2O
Molecular Weight 382.582
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Bunamidine is a anti-parasitic drug, which was approved by FDA for the treatment of tapeworms in cats and dogs (Scolaban 400 tablets).

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
SCOLABAN 400

Approved Use

The drug is intended for oral administration to dogs for the treatment of the tapeworms Dipylidium caninum, Taenia pisiformis and Echinococcus granulosus and cats for the treatment of the tapeworms Dipylidium caninum and Taenia taeniaeformis.
PubMed

PubMed

TitleDatePubMed
A NEW TAENIACIDE, BUNAMIDINE HYDROCHLORIDE: ITS EFFICIENCY AGAINST TAENIA PISIFORMIS AND DIPYLIDIUM CANINUM IN THE DOG AND HYDATIGERA TAENIAEFORMIS IN THE CAT.
1965 Apr 10
Evaluation of selected drugs for the treatment of canine echinococcosis.
1968
The Styx Field Trial: effect of treatment of the definitive host for tapeworms on larval forms in the intermediate host.
1978
The Hymenolepis diminuta-golden hamster (Mesocricetus auratus) model for the evaluation of gastrointestinal anticestode activity.
2004 Aug

Sample Use Guides

It is administered to dogs at the rate of 25 to 50 milligrams per kilogram of body weight. The drug should be given on an empty stomach and food should not be given for 3 hours following treatment.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:15:48 GMT 2023
Edited
by admin
on Fri Dec 15 15:15:48 GMT 2023
Record UNII
Y80LB0Q7CB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUNAMIDINE HYDROCHLORIDE
GREEN BOOK   MART.   MI   USAN  
USAN  
Official Name English
BUNAMIDINE HCL
Common Name English
BUNAMIDINE HYDROCHLORIDE [USAN]
Common Name English
1-NAPHTHALENECARBOXIMIDAMIDE, N,N-DIBUTYL-4-(HEXYLOXY)-, MONOHYDROCHLORIDE
Common Name English
BUNAMIDINE HYDROCHLORIDE [GREEN BOOK]
Common Name English
N,N-Dibutyl-4-(hexyloxy)-1-naphthamidine monohydrochloride
Systematic Name English
BUNAMIDINE HYDROCHLORIDE [MI]
Common Name English
BUNAMIDINE HYDROCHLORIDE [MART.]
Common Name English
NSC-106571
Code English
Classification Tree Code System Code
WHO-VATC QP52AX02
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
NCI_THESAURUS C250
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
CFR 21 CFR 520.222
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
Code System Code Type Description
MERCK INDEX
m597
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID7046837
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
ChEMBL
CHEMBL1355596
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
NSC
106571
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
ECHA (EC/EINECS)
213-890-2
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
DRUG BANK
DBSALT001667
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
MESH
C100222
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
FDA UNII
Y80LB0Q7CB
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
NCI_THESAURUS
C75211
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
CAS
1055-55-6
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
PUBCHEM
13985
Created by admin on Fri Dec 15 15:15:48 GMT 2023 , Edited by admin on Fri Dec 15 15:15:48 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY